col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


25 Results       Page 1

 [1] 
Elsevier: Journal of Drug Delivery Science and Technology
  original article Date Title Authors   All Authors
1 [GO] 2025―Mar―14 Subcutaneous Administration of an Endocrine-Mimetic, Slow-Release Protein Material Reduces the Severity of SARS-CoV-2 Infection Eloi Parladé, Ferran Tarrés-Freixas, Marianna T.P. Favaro, Jara Lascorz, Merce Márquez-Matínez, Rosa Mendoza, et al. (+9)
2 [GO] 2025―Feb―22 Navigating COVID-19: advancements in therapeutics and viral filtration technologies for Today's challenges and tomorrow's solutions Devesh Kapoor, Bhavna Kumar, Manmohan Singhal, Faiza Himasa Idris, Sonam M. Gandhi, Sankha Bhattachrya, et al. (+2)
3 [GO] 2025―Feb―05 Investigation of Moxifloxacin-loaded terpenes enriched cationic cerosomes (TECs) as an adjunct pulmonary therapy for COVID-19: in-silico study; D-optimal optimization; aerodynamic simulation assessment and cytotoxic evaluation. Rofida Albash, Carol Yousry, Mahmoud A. El Hassab, Wagdy M. Eldehna, Ahmed Adel Alaa-Eldin
4 [GO] 2024―Sep―14 Novel inhalable nano-based/microparticles for enhanced sustained pulmonary delivery of remdesivir - a patient malleable treatment for coronaviruses infection: in vitro aerosolization, cytotoxicity assays and antiviral activity studies. Shahinaze A. Fouad, Fady A. Malaak, Mahmoud H. Teaima, Samia Omar, Omnia Kutkat, Sammar Fathy Elhabal, Mohamed El-Nabarawi
5 [GO] 2024―Sep―13 Proanthocyanidins-based adjuvant for enhanced immune responses of SARS-CoV-2 subunit vaccine Yun Sun, Zibo Han, Lifang Du, Xinming Zhang, Yuan Li, Zehua Lei, et al. (+5)
6 [GO] 2024―May―20 Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies Hanan Elimam, Hossam S. El-Sawy, Marwa A.A. Fayed, Sara H. Mahmoud, Riham O. Bakr, Rasha M. Saleh, et al. (+2)
7 [GO] 2024―Mar―13 Silk fibroin-based hydrogel as injectable carrier for prolonged immunization of plant-based COVID-19 subunit vaccine Nopparuj Soomherun, Ruttanaporn Kriangsaksri, Wanlapa Tanticharakunsiri, Ngamlak Foongsawat, Waranyoo Phoolcharoen, Supannikar Tawinwung, et al. (+2)
8 [GO] 2023―Jun―08 Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond Amit Khurana, Prince Allawadhi, Vishakha Singh, Isha Khurana, Poonam Yadav, Kshirod Bihari Sathua, et al. (+4)
9 [GO] 2023―May―22 Corrigendum to “Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19” [J. Drug Deliv. Sci. Technol. 77 (2022) 103921] Sally Abou Taleb, Yassmin Moatasim, Mohamed GabAllah, Marwa Hasanein Asfour
10 [GO] 2023―May―15 Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness Asaikkutti Annamalai, Vimala Karuppaiya, Dhineshkumar Ezhumalai, Praseeja Cheruparambath, Kaviarasu Balakrishnan, Arul Venkatesan
11 [GO] 2023―Apr―20 Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: A double-blind clinical trial study Hamid Reza Samaee, Gohar Eslami, Golnar Rahimzadeh, Majid Saeedi, Alireza Davoudi Badabi, Kofi Asare-Addo, et al. (+6)
12 [GO] 2022―Dec―13 Development of favipiravir loaded PLGA nanoparticles entrapped in in-situ gel for treatment of Covid-19 via nasal route Vaishnavi Gattani, Shilpa Dawre
13 [GO] 2022―Oct―28 Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19 Sally Abou Taleb, Yassmin Moatasim, Mohamed GabAllah, Marwa Hasanein Asfour
14 [GO] 2022―Sep―17 Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants Teerapol Srichana, Charisopon Chunhachaichana, Roongnapa S, Somchai Sawatdee, Narumon Changsan
15 [GO] 2022―Sep―08 Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations Sally A. Helmy, Rasha M. El-Morsi, SohaA.M. Helmy, Soha M. El-Masry
16 [GO] 2022―Sep―06 Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review Manoj Kumar Sarangi, Sasmita Padhi, L.D. Patel, Goutam Rath, Sitansu Sekhar Nanda, Dong Kee Yi
17 [GO] 2022―Jun―28 Lipid nanoparticles in the development of mRNA vaccines for COVID-19 Barnabas Wilson, Kannoth Mukundan Geetha
18 [GO] 2021―Nov―06 Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients Behnam Hashemi, Akram Firouzi-amandi, Halimeh Amirazad, Mehdi Dadashpour, Milad Shirvaliloo, Davood Nasrabadi, et al. (+5)
19 [GO] 2021―Oct―05 The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19? Sheyda Ranjbar, Yousef Fatahi, Fatemeh Atyabi
20 [GO] 2021―Sep―15 Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: In silico and in vitro studies Dina B. Mahmoud, Walaa M. Ismail, Yassmin Moatasim, Omnia Kutkat, Aliaa N. ElMeshad, Shahira M. Ezzat, et al. (+7)
21 [GO] 2021―Jun―10 Nanotherapeutics for treating coronavirus diseases Thennakoon M. Sampath U. Gunathilake, Yern Chee Ching, Hiroshi Uyama, Cheng Hock Chuah
22 [GO] 2021―Feb―24 The pulmonary route as a way to drug repositioning in COVID-19 therapy Michelle Alvares Sarcinelli, Thalita Martins da Silva, Andressa Daniele Artico Silva, Beatriz Ferreira de Carvalho Patricio, Flávia Costa Mendes Paiva, Raissa Santos de Lima, et al. (+2)
23 [GO] 2021―Feb―21 Recent updates in COVID-19 with emphasis on inhalation therapeutics: nanostructured and targeting systems Ahmed A.H. Abdellatif, Hesham M. Tawfeek, Ahmed Abdelfattah, Gaber El-Saber Batiha, Helal F. Hetta
24 [GO] 2020―Sep―28 Can human overcome viral hijack-? Comprehensive review on COVID-19 in the view of diagnosis and mitigation across countries Maheswari Nagendran, Juliana John, Kavithakani Annamalai, Muthu Iswarya Gandhi Sethuraman, Nirkayani Balamurugan, Harish Kumar Rajendran, et al. (+4)
25 [GO] 2020―Sep―02 Type of Article: REVIEW Pharmaceutical Assessment of Polyvinylpyrrolidone (PVP): As Excipient from Conventional to Controlled Delivery Systems with a Spotlight on COVID-19 Inhibition Mallesh Kurakula, G.S.N. Koteswara Rao
 [1] 

25 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec